STOCK TITAN
  1. Home
  2. Sec-filings
  3. ADTX
  4. [EFFECT] Aditxt, Inc. SEC Filing

[EFFECT] Aditxt, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: June 30, 2025 4:30 P.M.
Form: S-1
CIK: 0001726711
Company Name: Aditxt, Inc.
File Number: 333-288211

Source: View Original Filing on SEC EDGAR

Stock ADTX logo
Aditxt Inc

NASDAQ:ADTX

ADTX Rankings

#7015 Ranked by Market Cap
N/A Ranked by Dividends

ADTX Latest News

Nov 18, 2025
Aditxt Provides Updates on its Growth Vision for bitXbio™, Planned Digital Asset Treasury, Pearsanta’s Planned IPO, And Evofem’s Plan to Regain a National Listing
Oct 29, 2025
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-113 Reverse Stock Split Effective at the Open of Trading on November 3, 2025
Oct 27, 2025
Aditxt Subsidiary Pearsanta Begins Enrollment in First Human Study of Blood-Based Diagnostic for Endometriosis, a Condition Affecting 190 Million Women Worldwide and Representing a $1.45 Billion Global Market
Oct 20, 2025
Evofem Announces Voting Results from Special Meeting of Stockholders
Sep 11, 2025
Evofem's "Say Vagina" Campaign Generates More than 2.5 Million Views Across Social Media Platforms

ADTX Latest SEC Filings

Feb 13, 2026
[8-K] Aditxt, Inc. Reports Material Event
Jan 30, 2026
[SCHEDULE 13G] Aditxt, Inc. Passive Investment Disclosure (>5%)
Jan 30, 2026
[8-K] Aditxt, Inc. Reports Material Event
Jan 28, 2026
[8-K] Aditxt, Inc. Reports Material Event
Dec 12, 2025
[424B5] Aditxt, Inc. Prospectus Supplement (Debt Securities)

ADTX Stock Data

812.00k
1.78M
Biotechnology
Pharmaceutical Preparations
Link
United States
RICHMOND